2021
DOI: 10.1007/s40618-021-01691-5
|View full text |Cite
|
Sign up to set email alerts
|

The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(16 citation statements)
references
References 53 publications
0
10
0
Order By: Relevance
“…In general, the treatment of the underlying reason of cytokine profile disruption is beneficial and may reverse the diseases' negative effects on fertilisation and pregnancy outcomes. A good example of this is PCOS, in which insulin resistance therapy, body weight reduction, and lifestyle changes, as well as pharmacological treatments, for example, metformin, can have a beneficial effect on the leptin levels and cytokine profile of patients [49][50][51].…”
Section: Practical Aspects and Unanswered Questionsmentioning
confidence: 99%
“…In general, the treatment of the underlying reason of cytokine profile disruption is beneficial and may reverse the diseases' negative effects on fertilisation and pregnancy outcomes. A good example of this is PCOS, in which insulin resistance therapy, body weight reduction, and lifestyle changes, as well as pharmacological treatments, for example, metformin, can have a beneficial effect on the leptin levels and cytokine profile of patients [49][50][51].…”
Section: Practical Aspects and Unanswered Questionsmentioning
confidence: 99%
“…Studies comparing metabolic effects of metformin and myo-inositol included only or mainly women with polycystic ovary syndrome and provided incongruent results. 25,26 However, at the beginning of the current study, glucose homeostasis markers did not differ between the study groups and therefore differences in insulin-sensitizing potencies of metformin and myo-inositol cannot explain our findings. They cannot be also related to the effect on levothyroxine absorption, which has not been affected by concomitant metformin ingestion.…”
Section: Discussionmentioning
confidence: 53%
“…This clearly suggests the existence of an association between hormonal, immunosuppressive and metabolic effects of both treatment options. Studies comparing metabolic effects of metformin and myo‐inositol included only or mainly women with polycystic ovary syndrome and provided incongruent results 25,26 . However, at the beginning of the current study, glucose homeostasis markers did not differ between the study groups and therefore differences in insulin‐sensitizing potencies of metformin and myo‐inositol cannot explain our findings.…”
Section: Discussionmentioning
confidence: 58%
“…Therefore, alternative treatment with fewer side effects would be beneficial in managing these patients. In recent years, several studies have analyzed the potential effects of inositol supplementation, suggesting that inositols are potent alternatives for metformin in treating PCOS [ 12 16 ].…”
Section: Introductionmentioning
confidence: 99%